VIMPAT 10 mg in 1 mL Oral Solution
RxNorm 995156
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 995156 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: VIMPAT 10 mg in 1 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Lacosamide 10 mg/ML Oral Solution [Vimpat]
(Atom ID: 3270829)
PSNPrescribable
Prescribable Name (PSN):
VIMPAT 10 mg in 1 mL Oral Solution
(Atom ID: 8699902)
SYPrescribable
Synonym (SY):
Vimpat 10 mg per 1 mL Oral Solution
(Atom ID: 8699903)
SYPrescribable
Synonym (SY):
Vimpat 10 mg/ML Oral Solution
(Atom ID: 3270830)
Patient Education
Lacosamide
Lacosamide is used to control partial onset seizures (seizures that involve only one part of the brain) in adults and children 4 years of age and older. Lacosamide is also used in combination with other medications to control primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 4 years of age and older. Lacosamide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.